GENW Genter Capital International Dividend ETF

ETF on NYSE (US) · Actively managed · Listing

Form N-PORT Jul 31, 2026 vs Apr 30, 2026 Filed with the SEC Sep 28, 2026
Book +6% $4.83M → $5.12M
Line items (Apr 30, 2026: 36) 36
In top 10 39%
Largest holding: Barclays PLC ($255K) 5.0%
Portfolio date Jul 31, 2026
New / increased 1 / 3
Reduced / closed 2 / 1
Unchanged 29
−100%

Most notable sale · AstraZeneca

AstraZeneca sold out

Shares went from 819 to 0 ($153K → $0). Was 3.2% of the Apr 30, 2026 portfolio.

New

Most notable buy · AstraZeneca PLC

New position in AstraZeneca PLC

819 units worth $139K. Now 2.7% of the portfolio.

Largest holding: Barclays PLC, unchanged, 9,257 shares ($255K).

Barclays PLC: 5.0% Banco Bilbao Vizcaya Argentaria S.A.: 4.4% BNP Paribas SA: 4.4% ABB Limited: 4.4% Mitsubishi UFJ Financial Group, Inc.: 4.3% Sumitomo Mitsui Financial Group, Inc.: 4.1% Vodafone Group Plc: 3.3% Enbridge Inc: 3.2% Allianz SE: 3.2% Enel SpA: 3.0% The other 26 positions: 60.7% $5.12M Holdings value
Current positions Top 10 % of book
Barclays PLC BCS $255K · unch. 5.0%
Banco Bilbao Vizcaya Argentaria S.A. BBVA $227K · unch. 4.4%
BNP Paribas SA $225K · +18% units 4.4%
ABB Limited $225K · unch. 4.4%
Mitsubishi UFJ Financial Group, Inc. MUFG $221K · −21% sh 4.3%
Sumitomo Mitsui Financial Group, Inc. SMFG $211K · −24% sh 4.1%
Vodafone Group Plc VOD $168K · unch. 3.3%
Enbridge Inc ENB $165K · unch. 3.2%
Allianz SE $163K · unch. 3.2%
Enel SpA $155K · unch. 3.0%

Slices are % of holdings value. Changes ("sh" shares, "units" other holdings) are in the quantity held against Apr 30, 2026.

Financial Services: 25.7% Energy: 7.9% Healthcare: 4.2% Communication Services: 3.3% Technology: 2.8% Consumer Defensive: 2.7% Basic Materials: 2.5% Utilities: 2.3% Other (1): 1.7% Unclassified: 47.0% 9 sectors
Sectors % of holdings value
Financial Services 25.7%
Energy 7.9%
Healthcare 4.2%
Communication Services 3.3%
Technology 2.8%
Consumer Defensive 2.7%
Basic Materials 2.5%
Utilities 2.3%
Other (1) 1.7%
Unclassified 47.0%
Banks - Diversified: 17.8% Oil & Gas Midstream: 5.7% Drug Manufacturers - General: 4.2% Telecom Services: 3.3% Communication Equipment: 2.8% Financial Conglomerates: 2.7% Tobacco: 2.7% Other (6): 13.8% Unclassified: 47.0% 13 industries
Industries % of holdings value
Banks - Diversified 17.8%
Oil & Gas Midstream 5.7%
Drug Manufacturers - General 4.2%
Telecom Services 3.3%
Communication Equipment 2.8%
Financial Conglomerates 2.7%
Tobacco 2.7%
Other (6) 13.8%
Unclassified 47.0%
Initiations 1 Value
AstraZeneca PLC AZN 2.7% of portfolio $139K
Increases 3 Change
MERCEDES-BENZ GROUP MBGYY $71.4K → $145K 2.2x
Imperial Brands PLC $94.3K → $149K +60%
BNP Paribas SA $158K → $225K +18%
Reductions 2 Change
Sumitomo Mitsui Financial Group, Inc. SMFG $229K → $211K −24%
Mitsubishi UFJ Financial Group, Inc. MUFG $225K → $221K −21%
Terminations 1 Change
AstraZeneca AZN was $153K −100%

Source: the fund's quarterly portfolio reports to the SEC, the portfolio of Jul 31, 2026 (Form N-PORT) vs the portfolio of Apr 30, 2026 (Form N-PORT). Percent changes are changes in the quantity held (shares, or units for holdings that are not a listed equity); dollar values are as reported at each period end. Each column is ranked by the estimated dollar size of the trade: a new or closed position at its value, otherwise the change in shares at the position's own period-end price. Where shares and price per share moved by inverse whole multiples (a split), the earlier share count is restated. Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.

Objective

Genter Capital International Dividend ETF's investment objective is to seek current income and long-term capital appreciation.

Principal investment strategies

Under normal market conditions, the Fund will invest at least 80% of its assets plus borrowings for investment purposes in foreign equity securities that have records of paying dividends. The Fund will invest primarily in companies with market capitalizations of $2 billion or higher at the time of initial purchase. In addition, the Fund will invest in a diversified portfolio of 25 to 50 securities typically spread across many economic sectors. Investments in and weightings of individual sectors will vary based on the Fund's investment sub-advisor's, RNC Capital Management, LLC d/b/a Genter Capital Management ("Genter Capital" or the "Sub-Advisor") assessment of valuation and the economic outlook using the process described below. Examples of conditions that will affect the weighting of sectors include recent relative performance of each sector to the overall market performance, economic conditions such as inflation and economic growth and expectations of economic growth in the upcoming period of time and how that sector might be affected more or less than other sectors, and economic growth rate and geopolitical conditions, military conflicts which can and typically affect availability and demand for natural resources that can have impact on one or more sectors relative to other sectors of the overall market economy. For example, the price of oil has a significant impact on the transportation sector, which can in turn have a significant impact on consumer goods and raw materials being transported. Another example which can have a significant impact on one or more sectors is tariffs. Tariffs imposed on either a country or a particular industry will increase the price and may reduce the supply as well. A tariff on consumer goods imported from China would impact retailers where those imported goods are sold. 2 The Fund defines foreign equity securities as equity securities of companies organized or having their principal place of business (location where they are subject to revenue tax) outside the U.S. The Fund's investments in foreign securities will primarily be in American Depository Receipts ("ADRs"), which are receipts that represent interests in foreign securities held on deposit by U.S. banks. The Fund may also invest up to 20% of its assets in domestic equity securities that have records of paying dividends and derive more than 30% of revenues from non-U.S. operations. The Sub-Advisor employs a three-step process in selecting the Fund's investments. The Sub-Advisor begins with a universe of those foreign publicly traded companies and domestic equity securities that derive more than 30% of revenues from non-U.S. operations that have paid a dividend in each of the previous four quarters. First, the Sub-Advisor uses publicly available filings, financial analyst's reports and research information available both publicly and by subscription or purchase to identify companies that have 1) market capitalizations greater than $2 billion, 2) dividend growth, which the Sub-Advisor defines as no quarters among the previous four with any dividend reduction and at least one of the most recent two quarters having a dividend increase, and 3) investment grade debt ratings. Second, a thorough fundamental analysis of the companies is conducted focusing on valuation and balance sheet and income statement information. Lastly, the three characteristics identified in the first step are evaluated further to view the dividend yield, assessment of likelihood of capital appreciation, and to assess the expected volatility and risk for each security.

Management and Contact

Adviser
OBP Capital LLC
Sub-adviser
Genter Capital Management
Portfolio managers

David Pescherine, Senior Vice President of the Sub-Advisor, David P. Klatt, Vice President of the Sub-Advisor, and Glen Nam, First Vice President of the Sub-Advisor are the Fund's portfolio managers and are jointly and primarily responsible for the day-to-day management of the Fund's portfolio.

Mr. Pescherine, Mr. Klatt, and Mr. Nam have managed the Fund since its inception in January 2025.

Phone
1-800-773-3863

Holdings as of Jul 31, 2026

36 lines, 18 linked, weights sum to 100.14% · Actively managed (N-CEN)

Holding Ticker / identifier Type Shares Change Weight Market value
Barclays PLC BCS 06738E204 Equity 9,257 0 4.98% $ 254.568K
Banco Bilbao Vizcaya US05946K1016 Equity 8,121 0 4.44% $ 226.982K
ABB Limited
US0003752047 Equity 2,278 0 4.39% $ 224.656K
BNP Paribas SA
US05565A2024 Equity 3,554 +550 4.39% $ 224.719K
Mitsubishi UFJ Finan US6068221042 Equity 9,863 −2,645 4.33% $ 221.424K
Sumitomo Mitsui Fina US86562M2098 Equity 8,167 −2,625 4.13% $ 211.362K
Vodafone Group PLC VOD 92857W308 Equity 10,660 0 3.29% $ 168.215K
Enbridge Inc CA29250N1050 Equity 3,037 0 3.23% $ 165.395K
Allianz SE
US0188201000 Equity 3,268 0 3.18% $ 162.616K
Enel SpA
US29265W2070 Equity 13,774 0 3.03% $ 154.958K
Orange SA
US6840601065 Equity 7,995 0 2.97% $ 152.005K
Imperial Brands PLC
US45262P1021 Equity 3,951 +1,475 2.92% $ 149.387K
Telefonaktiebolaget ERIC 294821608 Equity 14,818 0 2.84% $ 145.365K
MERCEDES-BENZ GROUP
MBGYY 233825207 Equity 10,773 +5,855 2.84% $ 145.22K
Novartis AG NVS 66987V109 Equity 925 0 2.82% $ 144.439K
BAE Systems PLC
US05523R1077 Equity 1,259 0 2.79% $ 142.985K
Carlsberg AS
US1427952023 Equity 4,790 0 2.78% $ 142.455K
ORIX Corp US6863301015 Equity 3,470 0 2.73% $ 139.876K
AstraZeneca PLC
AZN G0593M107 Other 819 new +819 2.72% $ 138.935K
AXA SA
AXAHY 054536107 Equity 2,674 0 2.71% $ 138.513K
British American Tob BTI 110448107 Equity 2,265 0 2.68% $ 137.372K
Manulife Financial C CA56501R1064 Equity 2,971 0 2.58% $ 132.031K
Nomura Holdings Inc US65535H2085 Equity 13,473 0 2.55% $ 130.419K
Rio Tinto PLC RIO 767204100 Equity 1,321 0 2.50% $ 127.939K
Pembina Pipeline Cor PBA 706327103 Equity 2,542 0 2.43% $ 124.38K
Koninklijke Ahold De
US5004675014 Equity 3,070 0 2.36% $ 120.528K
National Grid PLC NGG 636274409 Equity 1,453 0 2.27% $ 116.196K
BP PLC BP 055622104 Equity 2,519 0 2.23% $ 113.909K
CK Hutchison Holding
US12562Y1001 Equity 11,683 0 2.14% $ 109.353K
Komatsu Ltd
US5004584018 Equity 2,113 0 1.79% $ 91.641K
Schneider Electric S
US80687P1066 Equity 1,356 0 1.78% $ 90.96K
Honda Motor Co Ltd US4381283088 Equity 2,872 0 1.69% $ 86.476K
DSM-Firmenich AG
US23346J1034 Equity 7,268 0 1.54% $ 78.567K
Akzo Nobel NV
US0101995035 Equity 3,273 0 1.49% $ 76.326K
Sanofi SNY 80105N105 Equity 1,651 0 1.39% $ 71.125K
Goldman Sachs Financ
FGTXX 38141W273 Money market 62,036.9 −30,599.3 1.21% $ 62.037K

Trades Apr 30, 2026 to Jul 31, 2026

Holding Ticker Action Before After Change Value
AstraZeneca PLC AZN Closed 819 — −819 $ -153.456K
AstraZeneca PLC
AZN New — 819 +819 $ 138.935K
MERCEDES-BENZ GROUP
MBGYY Bought 4,918 10,773 +5,855 $ 78.925K
Sumitomo Mitsui Fina Sold 10,792 8,167 −2,625 $ -67.935K
Mitsubishi UFJ Finan Sold 12,508 9,863 −2,645 $ -59.38K
Imperial Brands PLC
Bought 2,476 3,951 +1,475 $ 55.77K
BNP Paribas SA
Bought 3,004 3,554 +550 $ 34.777K

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up